August 5, 2019
Vaccine evaluation subcommittee on July 31 The introduction of rotavirus vaccines to Japan’s public vaccination programs will have a good risk-benefit profile, but a “challenge remains” from a cost-effectiveness standpoint, a health ministry panel has said, pointing out the need...read more